# Genentech to invest $750M in device fill-finish facility in Hillsboro, Oregon

Genentech announced plans to invest approximately $750 million in a new device fill-finish manufacturing facility at its Hillsboro, Oregon campus. The expansion will double the facility size, create 250 high-wage manufacturing jobs and 200 construction jobs, with commercial operations expected to begin in 2031.

- Type: Expansion
- Announced: 2026-08-20
- Where: Hillsboro, Oregon, United States
- Value: $750.0M
- Jobs: 450
- Starts operating: 2031
- Status: announced
- Products: pre-filled syringes, autoinjectors, drug delivery devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Genentech](https://endata.com/companies/8218.md)
- [Roche Holdings Inc](https://endata.com/companies/16415.md) (partner)

## Sources

- [gene.com](https://www.gene.com/media/press-releases/15123/2026-08-20/genentech-announces-manufacturing-expans), 2026-08-20: "The investment will bring new end-to-end device filling capabilities to the site and expand Genentech's capacity to support its future pipeline of innovative medicines."
- [gene.com](https://www.gene.com/media/press-releases/15129/2026-09-28/genentech-breaks-ground-on-750-million-m), 2026-09-28: "The expansion will create approximately 250 high-wage manufacturing jobs."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.